KRAS and familial pancreatic carcinoma: For example, GMP-grade bioreactors, such as those from Quantum, have successfully produced large quantities of exosomes carrying Kras-G12D siRNA, demonstrating their potential to inhibit tumors in a pancreatic cancer model (104).